Company · Stevenage
Swanbio Therapeutics Limited
Research and experimental development on biotechnology
Official record Companies House · updated 27th September 2026 · Sources
Network
The large node is Swanbio Therapeutics Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.
Who leads it
Previous officers 11
- Dr John Tsai 2023-2024 View profile
- Alexander Brian Hamilton 2021-2024 View profile
- Patricia Allen 2021-2024 View profile
- Alison Lawton 2021-2024 View profile
- Danny Bar-Zohar 2020-2020 View profile
- Thomas D. Anderson 2019-2024 View profile
- Spyridon Papapetropoulos 2019-2019 View profile
- Anne Prener 2018-2020 View profile
- Dr Christopher John Hollowood 2018-2023 View profile
- Julius John Sheldon Knowles 2018-2023 View profile
- Rachel Lynn Salzman 2017-2018 View profile
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
About
- What it does
- Research and experimental development on biotechnology
- Incorporated
- 01/09/2017
- Registered office
- Stevenage
- Previous names
- Avistat BIO Limited (until 08/12/2017)
Avalon BIO Limited (until 24/10/2017)
Ownership
Owned by (2) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.
- Rachel Lynn Salzman ceased 2018-02-02
25-50% shares, 25-50% voting · notified 2017-09-01 - Spur Therapeutics Holdings Limited
75-100% shares, 25-50% voting, appoints directors · notified 2024-03-19
Group
- Swanbio Therapeutics Limited
is controlled by Rachel Lynn Salzman
Evidence
ceased 25-50% shares, 25-50% voting · notified 2017-09-01, ceased 2018-02-02 · source: Companies House PSC register
Ultimately controlled by Rachel Lynn Salzman.
Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.
Board analysis
Board DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
3 directors on the board
- James Albert Bircher Iii Director · appointed 2024
- Michael John Parini Director · appointed 2024
- Paul Matthew Schneider Director · appointed 2024
First-time vs portfolio directors
Portfolio (3)
- James Albert Bircher Iii Director · appointed 2024
- Michael John Parini Director · appointed 2024
- Paul Matthew Schneider Director · appointed 2024
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- 10942620
- Status
- Active
- Type
- Private Limited Company
- Accounts next due
- 30/09/2026
- Edition
- Register edition compiled 27th September 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data